CA2388333A1 - Method and compositions for treating pulmonary diseases - Google Patents

Method and compositions for treating pulmonary diseases Download PDF

Info

Publication number
CA2388333A1
CA2388333A1 CA002388333A CA2388333A CA2388333A1 CA 2388333 A1 CA2388333 A1 CA 2388333A1 CA 002388333 A CA002388333 A CA 002388333A CA 2388333 A CA2388333 A CA 2388333A CA 2388333 A1 CA2388333 A1 CA 2388333A1
Authority
CA
Canada
Prior art keywords
rolipram
pde
compounds
asthma
pde4
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002388333A
Other languages
English (en)
French (fr)
Inventor
Peter N. Goodfellow
Richard Nieman
Theodore J. Torphy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2388333A1 publication Critical patent/CA2388333A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002388333A 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases Abandoned CA2388333A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02
US60/163,158 1999-11-02
PCT/US2000/030113 WO2001032127A2 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Publications (1)

Publication Number Publication Date
CA2388333A1 true CA2388333A1 (en) 2001-05-10

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002388333A Abandoned CA2388333A1 (en) 1999-11-02 2000-11-01 Method and compositions for treating pulmonary diseases

Country Status (29)

Country Link
EP (1) EP1225866A4 (xx)
JP (1) JP2003513028A (xx)
KR (1) KR20020057988A (xx)
CN (1) CN1387404A (xx)
AP (1) AP2002002496A0 (xx)
AR (1) AR029189A1 (xx)
AU (1) AU1357501A (xx)
BG (1) BG106748A (xx)
BR (1) BR0015270A (xx)
CA (1) CA2388333A1 (xx)
CO (1) CO5261512A1 (xx)
CZ (1) CZ20021512A3 (xx)
DZ (1) DZ3225A1 (xx)
EA (1) EA200200518A1 (xx)
EC (1) ECSP003747A (xx)
HK (1) HK1049107A1 (xx)
HU (1) HUP0203152A3 (xx)
IL (1) IL149367A0 (xx)
MA (1) MA26841A1 (xx)
MX (1) MXPA02004350A (xx)
NO (1) NO20022057L (xx)
OA (1) OA12076A (xx)
PE (1) PE20011005A1 (xx)
PL (1) PL355261A1 (xx)
SK (1) SK7592002A3 (xx)
TR (1) TR200201211T2 (xx)
TW (1) TWI242431B (xx)
WO (1) WO2001032127A2 (xx)
ZA (1) ZA200203435B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA008108B1 (ru) * 2001-09-19 2007-04-27 Алтана Фарма Аг Комбинация нспвлс и ингибитора pde-4
US20040259863A1 (en) * 2001-10-31 2004-12-23 Hans-Michael Eggenweiler Type 4 phosphodiesterase inhibitors and uses thereof
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
EP1616569A1 (en) * 2003-03-31 2006-01-18 Kyowa Hakko Kogyo Co., Ltd. Medicinal composition
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
WO2006041121A1 (ja) * 2004-10-13 2006-04-20 Kyowa Hakko Kogyo Co., Ltd. 慢性皮膚疾患の治療および／または予防剤
WO2007045980A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
CN105381524A (zh) 2010-01-05 2016-03-09 微剂量治疗技术公司 吸入设备和方法
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0710109T3 (da) * 1993-06-18 2005-01-03 Smithkline Beecham Corp Fremgangsmåde til identifikation af en PDE IV inhibitor
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
JP2003513028A (ja) 2003-04-08
CO5261512A1 (es) 2003-03-31
EP1225866A2 (en) 2002-07-31
CN1387404A (zh) 2002-12-25
DZ3225A1 (fr) 2001-05-10
WO2001032127A3 (en) 2001-12-06
TR200201211T2 (tr) 2002-08-21
PL355261A1 (en) 2004-04-05
CZ20021512A3 (cs) 2003-04-16
KR20020057988A (ko) 2002-07-12
HK1049107A1 (zh) 2003-05-02
MA26841A1 (fr) 2004-12-20
IL149367A0 (en) 2002-11-10
EA200200518A1 (ru) 2002-10-31
OA12076A (en) 2006-05-04
ZA200203435B (en) 2003-06-25
TWI242431B (en) 2005-11-01
HUP0203152A3 (en) 2004-06-28
NO20022057L (no) 2002-06-27
ECSP003747A (es) 2002-05-23
BG106748A (en) 2003-02-28
SK7592002A3 (en) 2002-11-06
WO2001032127A2 (en) 2001-05-10
MXPA02004350A (es) 2002-11-07
BR0015270A (pt) 2002-06-18
NO20022057D0 (no) 2002-04-30
EP1225866A4 (en) 2004-04-21
PE20011005A1 (es) 2001-09-28
AR029189A1 (es) 2003-06-18
AU1357501A (en) 2001-05-14
HUP0203152A2 (hu) 2003-01-28
AP2002002496A0 (en) 2002-06-30

Similar Documents

Publication Publication Date Title
US6555583B2 (en) Therapies for treating pulmonary diseases
US20050070514A1 (en) Therapies for treating respiratory diseases
CZ219196A3 (en) Application of mometasonfuorate aqueous suspension for preparing a medicament for effective intranasal treatment of nasal allergy
US20040180918A1 (en) Novel therapeutic method
US20040176419A1 (en) Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases
CA2388333A1 (en) Method and compositions for treating pulmonary diseases
US20060035877A1 (en) Method and compositions for treating pulmonary diseases
JP2004505039A (ja) Ｃｏｐｄに付随する増悪の減少方法
AU7205701A (en) Method and compositions for treating an inflammatory disease
AU2004205324A1 (en) Method and compositions for treating pulmonary diseases
US20040171593A1 (en) Method and compositions for treating an inflammatory disease
EP1261331A1 (en) Method and compositions for treating fibrotic diseases
US20030018071A1 (en) Method and compositions for treating fibrotic diseases
US11376263B2 (en) Cyproterone acetate compositions and uses thereof
KR20050094810A (ko) 로플루미래스트와 ｒ,ｒ-포르모테롤을 포함하는 상승작용성조합물
AU2002310620A1 (en) Composition comprising a PDE-4 inhibitor and H1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment respiratory diseases
MXPA01001994A (en) Therapies for treating pulmonary diseases

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued